Item 16. FORM 10-K SUMMARY

4K characters. Original on sec.gov · Markdown

Item 16. FORM 10-K SUMMARY

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.


			NEWMONT CORPORATION

			By:			/s/ MARK D. EBEL
						Mark D. Ebel Interim Chief Legal Officer
						February 29, 2024

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on February 29, 2024.


Signature						Title

*****						President, Chief Executive Officer and Director
Thomas R. Palmer						(Principal Executive Officer)

*****						Executive Vice President and Chief Financial Officer
Karyn F. Ovelmen						(Principal Financial Officer)

*****						Group Head - Accounting
Joshua L. Cage						(Principal Accounting Officer)

Philip Aiken, AM*						Director

Patrick G. Awuah, Jr.*						Director

Gregory H. Boyce*						Non-Executive Chair

Bruce R. Brook*						Director

Maura J. Clark*						Director

Emma FitzGerald*						Director

Mary Laschinger*						Director

Sally-Anne Layman*						Director

José Manuel Madero Garza*						Director

René Médori*						Director

Jane Nelson*						Director

Julio M. Quintana*						Director

Susan N. Story*						Director



*By:			/s/ MARK D. EBEL
			Mark D. Ebel Attorney-in-Fact

SCH- 1

SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS


	Year Ended December 31,
	2023		2022		2021
	(in millions)
Deferred Income Tax Valuation Allowance
Balance at beginning of year	$	3,994	$	3,791	$	3,418
Additions due to acquisition of Newcrest	300		—		—
Additions to deferred income tax expense	565		370		769
Reduction of deferred income tax expense	(207)		(109)		(350)

Additions and reductions reflected in other components of the financial statements	—		(58)		(46)
Balance at end of year	$	4,652	$	3,994	$	3,791

Refer to Note 10 of the Consolidated Financial Statements for additional information.

SCH- 2

Previous: Item 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES